AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

RISPERIDONE 1 Mg ;

12 registrations across 1 African market— 12 active

Markets with RISPERIDONE 1 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Riscure 1mg
Film Coated Tablets
🇪🇬EgyptGlobal NAPI Pharmaceuticals - GNPactive
Schizoperdal
Syrup
🇪🇬EgyptDelta grand pharma for pharmaceutical industries - DGPactive
Apexidone
Oral Solution
🇪🇬EgyptApex pharmaactive
Psychodal
Oral Solution
🇪🇬EgyptEl Delta for Pharmaceutical Industries - Delta Pharmaactive
Risperidone 1 mg
Film Coated Tablets
🇪🇬Egyptpharaonia pharmaceuticals (pharo pharma)active
Riscure 1mg
Film Coated Tablets
🇪🇬EgyptGlobal NAPI Pharmaceuticals - GNPactive
Schizoperdal
Syrup
🇪🇬EgyptDelta grand pharma for pharmaceutical industries - DGPactive
Apexidone
Oral Solution
🇪🇬EgyptApex pharmaactive
Psychodal
Oral Solution
🇪🇬EgyptEl Delta for Pharmaceutical Industries - Delta Pharmaactive
Riscure
Oral Solution
🇪🇬EgyptGlobal NAPI Pharmaceuticals - GNPactive
Psychodal 1mg
Film Coated Tablets
🇪🇬EgyptEl Delta for Pharmaceutical Industries - Delta Pharmaactive
Risperidone 1 mg
Film Coated Tablets
🇪🇬Egyptpharaonia pharmaceuticals (pharo pharma)active

RISPERIDONE 1 Mg ; in Africa — Regulatory Overview

RISPERIDONE 1 Mg ; is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.